These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37231538)

  • 1. Polysaccharides polymers for glaucoma treatment-a review.
    Ahmed T; Islam MN; Monalisa R; Ehsan F; Huang SW
    Eur J Ophthalmol; 2024 Mar; 34(2):338-356. PubMed ID: 37231538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insight on updates in polysaccharides for ocular drug delivery.
    Chandra NS; Gorantla S; Priya S; Singhvi G
    Carbohydr Polym; 2022 Dec; 297():120014. PubMed ID: 36184137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan/hydroxyethyl cellulose inserts for sustained-release of dorzolamide for glaucoma treatment: In vitro and in vivo evaluation.
    Franca JR; Foureaux G; Fuscaldi LL; Ribeiro TG; Castilho RO; Yoshida MI; Cardoso VN; Fernandes SOA; Cronemberger S; Nogueira JC; Ferreira AJ; Faraco AAG
    Int J Pharm; 2019 Oct; 570():118662. PubMed ID: 31491481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular drug delivery system: a reference to natural polymers.
    Pahuja P; Arora S; Pawar P
    Expert Opin Drug Deliv; 2012 Jul; 9(7):837-61. PubMed ID: 22703523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on revolutionizing ophthalmic therapy: Unveiling the potential of chitosan, hyaluronic acid, cellulose, cyclodextrin, and poloxamer in eye disease treatments.
    Wang TJ; Rethi L; Ku MY; Nguyen HT; Chuang AE
    Int J Biol Macromol; 2024 Jul; 273(Pt 2):132700. PubMed ID: 38879998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progression of drug delivery system for glaucoma].
    Xu Y; Lyu L
    Zhonghua Yan Ke Za Zhi; 2014 Dec; 50(12):946-51. PubMed ID: 25619186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for Polymers Used in Ocular Drug Delivery.
    Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
    Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained release ocular drug delivery systems for glaucoma therapy.
    Al-Qaysi ZK; Beadham IG; Schwikkard SL; Bear JC; Al-Kinani AA; Alany RG
    Expert Opin Drug Deliv; 2023; 20(7):905-919. PubMed ID: 37249548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.
    Luo Y; Wang Q
    Int J Biol Macromol; 2014 Mar; 64():353-67. PubMed ID: 24360899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbohydrate polymer-based bioadhesive formulations and their potentials for the treatment of ocular diseases: A review.
    Tang X; Liu J; Yan R; Peng Q
    Int J Biol Macromol; 2023 Jul; 242(Pt 3):124902. PubMed ID: 37210054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release.
    Rupenthal ID; Green CR; Alany RG
    Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
    Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.
    Natarajan JV; Chattopadhyay S; Ang M; Darwitan A; Foo S; Zhen M; Koo M; Wong TT; Venkatraman SS
    PLoS One; 2011; 6(9):e24513. PubMed ID: 21931735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and evaluation of performance characteristics of timolol-loaded composite ocular films as potential delivery platforms for treatment of glaucoma.
    Tighsazzadeh M; Mitchell JC; Boateng JS
    Int J Pharm; 2019 Jul; 566():111-125. PubMed ID: 31129346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained ocular delivery of brimonidine tartrate using ion activated in situ gelling system.
    Geethalakshmi A; Karki R; Jha SK; Venkatesh DP; Nikunj B
    Curr Drug Deliv; 2012 Mar; 9(2):197-204. PubMed ID: 22283647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical management of glaucoma: focus on ophthalmologic drug delivery systems of timolol maleate.
    Sah AK; Suresh PK
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):448-459. PubMed ID: 27002850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why chitosan could be apt candidate for glaucoma drug delivery - An overview.
    Kumara BN; Shambhu R; Prasad KS
    Int J Biol Macromol; 2021 Apr; 176():47-65. PubMed ID: 33581206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dental delivery systems of antimicrobial drugs using chitosan, alginate, dextran, cellulose and other polysaccharides: A review.
    Paul M; Pramanik SD; Sahoo RN; Dey YN; Nayak AK
    Int J Biol Macromol; 2023 Aug; 247():125808. PubMed ID: 37460072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.